Seroconversion after influenza vaccination in patients with lung cancer
- PMID: 10389999
- PMCID: PMC2362985
- DOI: 10.1038/sj.bjc.6690342
Seroconversion after influenza vaccination in patients with lung cancer
Abstract
There are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response rate is comparable to that obtained from healthy volunteers.
Similar articles
-
Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.J Med Virol. 2009 Apr;81(4):722-7. doi: 10.1002/jmv.21186. J Med Virol. 2009. PMID: 19235853 Clinical Trial.
-
Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.Rheumatology (Oxford). 2009 Oct;48(10):1294-9. doi: 10.1093/rheumatology/kep200. Epub 2009 Aug 19. Rheumatology (Oxford). 2009. PMID: 19692457
-
Influenza vaccination in patients with breast cancer: a case-series analysis.Med Sci Monit. 2006 Aug;12(8):CR332-6. Epub 2006 Jul 12. Med Sci Monit. 2006. PMID: 16865064 Clinical Trial.
-
Immunogenicity and protective efficacy of influenza vaccination.Virus Res. 2004 Jul;103(1-2):133-8. doi: 10.1016/j.virusres.2004.02.025. Virus Res. 2004. PMID: 15163501 Review. No abstract available.
-
Immunosenescence: role and measurement in influenza vaccine response among the elderly.Vaccine. 2007 Apr 20;25(16):3066-9. doi: 10.1016/j.vaccine.2007.01.025. Epub 2007 Jan 16. Vaccine. 2007. PMID: 17275144 Review.
Cited by
-
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).Ann Oncol. 2018 Jun 1;29(6):1354-1365. doi: 10.1093/annonc/mdy117. Ann Oncol. 2018. PMID: 29688266 Free PMC article. Review.
-
Vaccination recommendations for the hematology and oncology and post-stem cell transplant populations.J Adv Pract Oncol. 2012 Mar;3(2):71-83. doi: 10.6004/jadpro.2012.3.2.2. J Adv Pract Oncol. 2012. PMID: 25031932 Free PMC article. Review.
-
COVID-19 vaccine development from the perspective of cancer patients.Hum Vaccin Immunother. 2021 Oct 3;17(10):3281-3287. doi: 10.1080/21645515.2021.1943988. Epub 2021 Jun 25. Hum Vaccin Immunother. 2021. PMID: 34170788 Free PMC article. Review.
-
Influenza vaccines in immunosuppressed adults with cancer.Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD008983. doi: 10.1002/14651858.CD008983.pub3. Cochrane Database Syst Rev. 2018. PMID: 29388675 Free PMC article.
-
Practical review of immunizations in adult patients with cancer.Hum Vaccin Immunother. 2015;11(11):2606-14. doi: 10.1080/21645515.2015.1062189. Epub 2015 Jun 25. Hum Vaccin Immunother. 2015. PMID: 26110220 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical